These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17613711)

  • 41. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
    Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
    J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment.
    Stankoff B; Calvez V; Suarez S; Bossi P; Rosenblum O; Conquy L; Turell E; Dubard T; Coutellier A; Baril L; Bricaire F; Lacomblez L; Lubetzki C
    Eur J Neurol; 1999 Nov; 6(6):669-75. PubMed ID: 10529754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.
    Legoff J; Bouhlal H; Grésenguet G; Weiss H; Khonde N; Hocini H; Désiré N; Si-Mohamed A; de Dieu Longo J; Chemin C; Frost E; Pépin J; Malkin JE; Mayaud P; Bélec L
    J Clin Microbiol; 2006 Feb; 44(2):423-32. PubMed ID: 16455895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.
    Bertine M; Gueudin M; Mélard A; Damond F; Descamps D; Matheron S; Collin F; Rouzioux C; Plantier JC; Avettand-Fenoel V
    J Clin Microbiol; 2017 Sep; 55(9):2850-2857. PubMed ID: 28701422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O.
    de Baar MP; van Dooren MW; de Rooij E; Bakker M; van Gemen B; Goudsmit J; de Ronde A
    J Clin Microbiol; 2001 Apr; 39(4):1378-84. PubMed ID: 11283059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel real-time multiplex reverse transcriptase-polymerase chain reaction for the detection of HIV-1 RNA by using dual-specific armored RNA as internal control.
    Huang J; Yang CM; Wang LN; Meng S; Deng W; Li JM
    Intervirology; 2008; 51(1):42-9. PubMed ID: 18311080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control.
    Ferns RB; Garson JA
    J Virol Methods; 2006 Jul; 135(1):102-8. PubMed ID: 16563526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples.
    Tang N; Huang S; Salituro J; Mak WB; Cloherty G; Johanson J; Li YH; Schneider G; Robinson J; Hackett J; Swanson P; Abravaya K
    J Virol Methods; 2007 Dec; 146(1-2):236-45. PubMed ID: 17707519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome.
    Lazarini F; Seilhean D; Rosenblum O; Suarez S; Conquy L; Uchihara T; Sazdovitch V; Mokhtari K; Maisonobe T; Boussin F; Katlama C; Bricaire F; Duyckaerts C; Hauw JJ
    J Neurovirol; 1997 Aug; 3(4):299-303. PubMed ID: 9291238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load.
    Villahermosa ML; Thomson M; Vázquez de Parga E; Cuevas MT; Contreras G; Pérez-Alvarez L; Delgado E; Manjón N; Medrano L; Nájera R
    J Hum Virol; 2000; 3(1):27-34. PubMed ID: 10774804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder.
    Ramos FM; Delgado-Vélez M; Ortiz ÁL; Báez-Pagán CA; Quesada O; Lasalde-Dominicci JA
    J Neurovirol; 2016 Jun; 22(3):327-35. PubMed ID: 26567012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.
    Elbeik T; Hoo BS; Campodonico ME; Dileanis J; Fay FF; Bortolozzi RL; Benetti MS; Fay OH; Marlowe N; Petrauskene O; Chernoff D; Smith L; Ng VL
    J Hum Virol; 2001; 4(6):317-28. PubMed ID: 12082398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy.
    Haas DW
    J Neurovirol; 2004; 10 Suppl 1():33-7. PubMed ID: 14982737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Vener T; Nygren M; Andersson A; Uhlén M; Albert J; Lundeberg J
    J Clin Microbiol; 1998 Jul; 36(7):1864-70. PubMed ID: 9650926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia.
    Fujimura RK; Goodkin K; Petito CK; Douyon R; Feaster DJ; Concha M; Shapshak P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):146-52. PubMed ID: 9390565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CSF, plasma viral load and HIV associated dementia.
    Robertson K; Fiscus S; Kapoor C; Robertson W; Schneider G; Shepard R; Howe L; Silva S; Hall C
    J Neurovirol; 1998 Feb; 4(1):90-4. PubMed ID: 9531015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The reverse transcriptase sequence of human immunodeficiency virus type 1 is under positive evolutionary selection within the central nervous system.
    Huang KJ; Alter GM; Wooley DP
    J Neurovirol; 2002 Aug; 8(4):281-94. PubMed ID: 12161813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.